Foresee Home for Monitoring Age Related Macular Degeneration (AMD)

Study Overview
=================
Brief Summary
-----------------
The FORESEE HOME is intended for the early detection of central and paracentral irregularities (abnormalities) in the visual field, most commonly associated with AMD. However, the device has ability to detect the development of the lesion post treatment and therefore to asses in determination of the next treatment.

Detailed Description
-----------------
The FORESEE HOME is intended for the early detection of central and paracentral irregularities (abnormalities) in the visual field, most commonly associated with AMD. However, the device has ability to detect the development of the lesion post treatment and therefore to asses in determination of the next treatment. The OCT May be use as well to identify choroidal neovascularization (CNV). Comparison between the two methods will allow better understanding of both devices. The FORESEE HOME can use as an assessment tool for the progression and success of the treatment given to AMD lesions. Therefore, evaluation the size and the location of the treated lesions may serve as an additional tool.

Official Title
-----------------
Foresee Home for Monitoring Age Related Macular Degeneration (AMD)

Conditions
-----------------
Age Related Macular Degeneration

Intervention / Treatment
-----------------
* Device: Foresee Home


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Capable and willing to sign a consent form and participate in the study Subjects diagnosed as CNV under treatment or Intermediate AMD in at least one eye Did not perform more then 10 anti- VEGF injections Age >50 years VA with habitual correction >6/45 in the study eye Computer users Exclusion Criteria: Evidence of macular disease other than AMD or glaucoma in the study eye Presence of any significant media opacity that precludes a clear view of the macular area as identified in the study eye by biomicroscopy, Any non-macular related ocular surgery performed within 3 months prior to study entry in the target eye

Ages Eligible for Study
-----------------
Minimum Age: 50 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Dry AMD<br>Intermediate AMD subjects | Device: Foresee Home<br>* using the Foresee home device<br>|
| Wet - treated AMD<br>AMD subjects under treatments | Device: Foresee Home<br>* using the Foresee home device<br>|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| To investigate the FORESEE HOME ability to diagnose AMD in different stages |  | 1 year | 

Secondary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| To investigate the correlation between visual fields (VF) defects map generated by the FORESEE HOME and features of the choroidal neovascular lesions (CNV) demonstrated by Optical Coherence Tomography(OCT). |  | 1 year | 

 Terms related to the study
=================
Keywords Provided by Centre Hospitalier Valida
-----------------
AMD, CNV